Discontinued — last reported Q4 '25
Truist Financial Interest Paid decreased by 9.8% to $2.26B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.0%, from $2.38B to $2.26B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 85.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $213.00M | $194.00M | $204.00M | $156.00M | $274.00M | $552.00M | $1.03B | $1.67B | $2.37B | $2.39B | $2.71B | $2.83B | $2.97B | $2.87B | $2.68B | $2.38B | $2.59B | $2.60B | $2.51B | $2.26B |
| QoQ Change | — | -8.9% | +5.2% | -23.5% | +75.6% | +101.5% | +85.7% | +62.6% | +42.4% | +0.6% | +13.4% | +4.4% | +4.9% | -3.1% | -6.9% | -11.1% | +8.9% | +0.5% | -3.7% | -9.8% |
| YoY Change | — | — | — | — | +28.6% | +184.5% | +402.5% | +968.6% | +766.4% | +332.8% | +164.2% | +69.5% | +24.9% | +20.3% | -1.2% | -15.9% | -12.7% | -9.5% | -6.4% | -5.0% |